This is good news.
Federal authorities have announced that they are reviewing the possibility of loosening the classification of marijuana, and if this happens, it could have a far-reaching impact on how the substance is used in medical settings, experts said.
Marijuana is currently classified as a Schedule I drug, meaning it is listed alongside heroin and LSD as among the "most dangerous drugs" and has "no currently accepted medical use and a high potential for abuse."
The Drug Enforcement Agency announced last week that it is reviewing the possibility of reclassifying it as a Schedule II drug, which would put it in the same category as Ritalin, Adderal and oxycodone.
This matters because we don't even know the full medical benefits of marijuana.
We know that medical marijuana has good evidence for treatment for a handful of medical conditions," Hill said. "There are thousands of people who are using medical marijuana for a whole host of medical conditions," where the efficacy has yet to be thoroughly studied.
By changing the classification of the drug, Hill said researchers and doctors could find out how effective marijuana is in other conditions.
"We could move toward a more evidence-based use of medical marijuana," Hill said.
This was promoted by political pressure from U.S. Senators, proving that Congress has occasional uses.
The DEA along with the U.S. Department of Health and Human Services and Office of National Drug Control Policy announced they would review marijuana's classification after multiple letters from senators last year, including Sen. Elizabeth Warren, D-Massachusetts, and Sen.Kirsten Gillibrand, D-New York.
"For too long schedule I status for marijuana has been a barrier for necessary research, and as a result countless Americans can't get access to medicine they desperately need," Gillibrand said in a statement last week. "It's past due for the DEA to reconsider marijuana's status. I am hopeful that antiquated ideology won't continue to stand in the way of science and that the DEA will reschedule marijuana to schedule II."
I think it's likely that the DEA will “review” the issue and decide that they've been correct for the past 60 years. They'll then refuse to make any changes and use that decision as a club to beat critics for the next 60 years. I'm hoping that I'm wrong though.